The first stop for professional medicines advice

Ondansetron

Published
Topics: CCG commissioned new medicinesGastrointestinal disordersMental health and illness · New MedicinesOndansetronPatent expiriesSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Zofran · Novartis Pharmaceuticals UK Ltd
    2. Zofran Melt · Novartis Pharmaceuticals UK Ltd
  4. Lactation Safety Information

dm+d

108418007

Articles

Treating nausea during breastfeeding

26 March 2024

How should medicines be dosed in children who are obese?

28 May 2021Review on how to calculate medicine doses in children who are obese which includes a table on commonly prescribed medicines.
Search Articles

Medicine Compliance Aid Stability

ZofranNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Zofran
Tablets f/c 4mg, 8mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light and store in airtight containers.
22 November 2022
Usage of Medicines in Compliance Aids

Zofran MeltNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Zofran Melt
Oral lyophilisates 4mg, 8mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Tablet designed to dissolve on tongue - unsuitable for MCA
22 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Caution
Alternative anti-emetic if appropriate
5HT3-receptor antagonist
No published evidence of safety
Used in infants > 1 month
Safety in Lactation: Drugs used in nausea and vertigo
15 July 2019
Bibliography